StockpollyBeta
Get App
Popularity #3,726
IMDX · NASDAQ · Medical - Diagnostics & Research

Insight Molecular Diagnostics (IMDX)

Develops molecular diagnostic tests for transplant rejection and oncology therapy programs.

$4.14
After hours+0.03 (+0.73%)
At close$4.11(+2.49%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000001210100
Cost of revenue000001100110
Gross profit0000011000−10
71695143481011101012
Research & development232232334654
323343444455
Selling & marketing010110111022
General & administrative323233333433
Other expenses1114−1729133002
Operating income−7−16−9−5−14−34−7−10−11−10−10−11
000000000−1360
Interest expense000000000000
Other non-operating income0−11000000013−60
Income before tax−6−16−9−5−13−34−7−10−11−23−4−11
Net income from continuing operations−6−16−9−5−13−34−7−10−11−23−4−11
Net income−6−16−9−5−13−34−7−10−11−23−4−11
EPS, basic−$0.81−$1.96−$1.13−$0.36−$0.98−$1.93−$0.26−$0.30−$0.34−$0.75−$0.12−$0.31
EPS, diluted−$0.81−$1.96−$1.13−$0.36−$0.98−$1.93−$0.26−$0.30−$0.34−$0.75−$0.12−$0.31
Weighted average shares, basic888131417263232303537
Weighted average shares, diluted888131417263232303537
EBITDA−6−5−9−4−13−33−6−9−10−22−4−11
Depreciation & amortization000001011111
EBIT−6−5−9−5−13−33−7−10−11−23−4−11